RoosterBio Cell Manufacturing Experts and Biomanufacturing Leaders to Discuss hMSC BioProcess Solutions at Biotech Week Boston

Share Article

RoosterBio will share their advanced technology solutions for the biomanufacturing of cell, gene and extracellular vesicle therapies during the BioProcess International Conference

News Image
RoosterBio cell manufacturing experts will share strategies and solutions for rapidly streamlining the path to clinical manufacturing.

RoosterBio, Inc, a leading supplier of innovative human mesenchymal stem/stromal cell (hMSC) biomanufacturing systems, will present and exhibit during Biotech Week Boston at the BioProcess International (BPI) Conference & Exhibition and Cell & Gene Therapy BioProcessing & Commercialization Meeting September 9-12, 2019 in Boston, MA. This event, one of the largest bioprocessing events in the world, brings science, technologies and partners together to accelerate promising biologics toward commercial success. RoosterBio cell manufacturing experts will share strategies and solutions for rapidly streamlining the path to clinical manufacturing.

Featured Talks
On Monday, September 9, 2019 at 10am, RoosterBio’s Vice President of Analytical, Product & Process Development Taby Ahsan, PhD will give a presentation titled, “Radically Simplifying Scale-Up of hMSCs” during the Pre-Conference Symposia at the Cell & Gene Therapy Meeting. This pre-conference workshop is under the Tissue track and Next Generation Tools for Manufacturing Regenerative Medicine Products at Scale.

On the first day of the main conference agenda, Jon A. Rowley, PhD, Founder & Chief Product Officer for RoosterBio will give a presentation on Tuesday, September 10, 2019 at 11:55am at the Cell & Gene Therapy Meeting under Exosomes track and the Pre-Clinical and Clinical Development for Cell, Gene and CAR-T Therapies. Dr. Rowley will be speaking on the topic of “Exosomes and Their Potential for Scalable Manufacturing Platforms.”

Featured Posters
Dr. Rowley and RoosterBio Process Engineer Robert Kirian will present posters during the poster sessions September 10-12, 2019. These posters include:

  • Scaling a Xeno-Free Fed-Batch Microcarrier Suspension Bioreactor System to the Production Scale (50L) for Manufacturing XF hMSCs – Poster #B24
  • MSC-EVs Manufactured in Scalable 3D Bioreactor Systems – Poster #B26

RoosterBio will be exhibiting at booth number 1507 throughout the duration of the conference at the Boston Convention & Exhibition Center. Additional conference details can be located on the conference website at https://lifesciences.knect365.com/cell-therapy-bioprocessing.

About RoosterBio, Inc
RoosterBio, Inc. is a privately held cell manufacturing platform technology company focused on accelerating the development of a sustainable regenerative medicine industry, one customer at a time. RoosterBio's products are high-volume, affordable, and well-characterized adult human mesenchymal stem/stromal cells (hMSCs) paired with highly engineered media systems. RoosterBio has simplified and standardized how stem cells are purchased, expanded, and used in development, leading to marked time and costs savings for customers. RoosterBio's innovative products are ushering in a new era of productivity and standardization into the field, accelerating the road to discovery in Regenerative Medicine. For more information on RoosterBio, please visit http://www.roosterbio.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sandy Applebee, Marketing Communications
Visit website